- Home
- PDCC vs APLT Comparison
PDCC vs APLT Comparison
Compare PDCC & APLT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PDCC
- APLT
- Stock Information
- Founded
- PDCC N/A
- APLT 2016
- Country
- PDCC
- APLT United States
- Employees
- PDCC N/A
- APLT N/A
- Industry
- PDCC
- APLT Biotechnology: Pharmaceutical Preparations
- Sector
- PDCC
- APLT Health Care
- Exchange
- PDCC NYSE
- APLT Nasdaq
- Market Cap
- PDCC 138.6M
- APLT 128.0M
- IPO Year
- PDCC N/A
- APLT 2019
- Fundamental
- Price
- PDCC $20.43
- APLT $0.88
- Analyst Decision
- PDCC
- APLT Buy
- Analyst Count
- PDCC 0
- APLT 6
- Target Price
- PDCC N/A
- APLT $6.10
- AVG Volume (30 Days)
- PDCC N/A
- APLT 12.1M
- Earning Date
- PDCC N/A
- APLT 11-07-2024
- Dividend Yield
- PDCC N/A
- APLT N/A
- EPS Growth
- PDCC N/A
- APLT N/A
- EPS
- PDCC N/A
- APLT N/A
- Revenue
- PDCC N/A
- APLT N/A
- Revenue This Year
- PDCC N/A
- APLT N/A
- Revenue Next Year
- PDCC N/A
- APLT $2,664.24
- P/E Ratio
- PDCC N/A
- APLT N/A
- Revenue Growth
- PDCC N/A
- APLT N/A
- 52 Week Low
- PDCC N/A
- APLT $0.84
- 52 Week High
- PDCC N/A
- APLT $10.62
- Technical
- Relative Strength Index (RSI)
- PDCC N/A
- APLT 16.80
- Support Level
- PDCC N/A
- APLT $0.95
- Resistance Level
- PDCC N/A
- APLT $1.14
- Average True Range (ATR)
- PDCC 0.00
- APLT 0.16
- MACD
- PDCC 0.00
- APLT 0.05
- Stochastic Oscillator
- PDCC 0.00
- APLT 4.60
About PDCC PEARL DIVER CREDIT COMPANY INC
PEARL DIVER CREDIT COMPANY INC is a non-diversified closed ended management investment company.
About APLT Applied Therapeutics Inc.
Applied Therapeutics Inc is a clinical-stage biopharmaceutical company, developing a pipeline of novel product candidates against validated molecular targets in indications of high unmet medical need. The company's drug compounds pipeline includes, AT-007 which is a novel central nervous system, penetrant ARI that it is developing for the treatment of rare metabolic diseases, including Galactosemia and Sorbitol Dehydrogenase (SORD) Deficiency, AT-001 for the treatment of diabetic cardiomyopathy, and AT-003 for the treatment of diabetic retinopathy.